狂野欧美激情性xxxx欧美I 成人性生交大片免费看中文网站I 日韩视频一区二区在线I 国产中的精品av小宝探花I 黄色国产在线I 久久精品视频在线观看I 在线天堂8√

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > pSK8
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
pSK8
pSK8
規格:
貨期:
編號:B173045
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 pSK8
商品貨號 B173045
Designations pSK8
Species Homo sapiens, human
Depositors M Barbacid, S Katzav
Vector
Construct size (kb): 5.260000228881836
Insert
DNA: cDNA
Insert lengths(kb): 2.299999952316284
Tissue: tumor DNA activated during transfection
Gene product: vav 1 oncogene [VAV]
Insert Size (kb) 2.300
Media ATCC® Medium 1227: LB Medium (ATCC medium 1065) with 50 mcg/ml ampicillin
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Comments
Restriction digests of the clone give the following sizes (kb): EcoRI--2.9, 2.3; ClaI--4.2, 1.37; BamHI--5.25.
The proto-vav gene is not expressed at detectable levels in epithelial, mesenchymal or neuroectodermal cell lines but is readily detected in cell lines of hematopoietic origin.
A partial cDNA clone corresponding to nucleotides 593 to 2765 (with ATG initiator codon at nt 111).
The probe was generated by the depositors while both were at the Frederick Cancer Research Facility, Frederick, MD 21701.
The insert was cloned from a third cycle NIH 3T3 cell transfectant originally transformed with DNA derived from human esophageal carcinoma. The vav oncogene was activated during gene transfer.
References

Katzav S, et al. VAV, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8: 2283-2290, 1989. PubMed: 2477241

Mariano Barbacid, personal communication

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |